tiprankstipranks
Advertisement
Advertisement

BAYRY Stock Latest News

Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial
Company AnnouncementsHimalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial
4d ago
ORIC
Trump Trade: President warns communities against rejecting data centers
PremiumThe Fly
Trump Trade: President warns communities against rejecting data centers
6d ago
AZN
LLY
Bayer, Takeda expected to announce new pricing deals with White House, FT says
PremiumThe Fly
Bayer, Takeda expected to announce new pricing deals with White House, FT says
7d ago
AZN
LLY
Bayer announces presentation of results from Phase III REVEAL study
PremiumThe Fly
Bayer announces presentation of results from Phase III REVEAL study
8d ago
Bayer’s MOSAIC-TTR Study: Real-World Data Push for Acoramidis in ATTR-CM
PremiumCompany Announcements
Bayer’s MOSAIC-TTR Study: Real-World Data Push for Acoramidis in ATTR-CM
11d ago
BAYRY
Bayer Tests New Sepsis Clotting Drug With Aspirin: Early Trial Signals For BAYRY Investors
PremiumCompany AnnouncementsBayer Tests New Sepsis Clotting Drug With Aspirin: Early Trial Signals For BAYRY Investors
12d ago
BAYRY
Bayer’s Adempas Trial Update: What a Terminated Heart-Lung Study Means for BAYRY
Premium
Company Announcements
Bayer’s Adempas Trial Update: What a Terminated Heart-Lung Study Means for BAYRY
18d ago
BAYRY
Bayer to present data from cardiovascular, kidney, stroke programs at ESC 2026
Premium
The Fly
Bayer to present data from cardiovascular, kidney, stroke programs at ESC 2026
18d ago
Bayer Backs BlueRock’s CLARICO Eye Study, Extending Its Bet on Cell Therapy for Vision Loss
PremiumCompany Announcements
Bayer Backs BlueRock’s CLARICO Eye Study, Extending Its Bet on Cell Therapy for Vision Loss
19d ago
BAYRY
Bayer Probes Sevabertinib–Metformin Combo In New Phase 1 Study
PremiumCompany Announcements
Bayer Probes Sevabertinib–Metformin Combo In New Phase 1 Study
1M ago
BAYRY
Bayer price target raised to EUR 61 from EUR 50 at JPMorgan
PremiumThe Fly
Bayer price target raised to EUR 61 from EUR 50 at JPMorgan
1M ago
Bayer’s Rivaroxaban PAD Study Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
Bayer’s Rivaroxaban PAD Study Reaches Completion: What Investors Should Watch Next
1M ago
BAYRY
Bayer AG Earnings Call Balances Growth And Litigation
PremiumCompany AnnouncementsBayer AG Earnings Call Balances Growth And Litigation
1M ago
Bayer raises FY26 sales view to EUR 44.7B-EUR 46.7B from EUR 44.5B-EUR 46.5B
Premium
The Fly
Bayer raises FY26 sales view to EUR 44.7B-EUR 46.7B from EUR 44.5B-EUR 46.5B
1M ago
Bayer reports Q2 core EPS EUR 0.95 vs. EUR 1.14 last year
Premium
The Fly
Bayer reports Q2 core EPS EUR 0.95 vs. EUR 1.14 last year
1M ago
Bayer says ‘advancing’ on strategic priorities
PremiumThe Fly
Bayer says ‘advancing’ on strategic priorities
1M ago
Bayer AG (BAYRY) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Bayer AG (BAYRY) Q2 Earnings Cheat Sheet
1M ago
Bayer Halts Mirena Phase 3 Trial in Uterine Health: What It Means for BAYRY Investors
PremiumCompany Announcements
Bayer Halts Mirena Phase 3 Trial in Uterine Health: What It Means for BAYRY Investors
1M ago
BAYRY
One A Day introduces new Women’s Multi Gummy formula
PremiumThe Fly
One A Day introduces new Women’s Multi Gummy formula
1M ago
Bayer Refines Nurandociguat Tablet in New Phase 1 Study, Keeping CKD Pipeline on Track
PremiumCompany AnnouncementsBayer Refines Nurandociguat Tablet in New Phase 1 Study, Keeping CKD Pipeline on Track
2M ago
BAYRY
Kairos Pharma announces collaboration with Bayer to enhance XOFIGO
Premium
The Fly
Kairos Pharma announces collaboration with Bayer to enhance XOFIGO
2M ago
KAPA
Bayer, Henry Ford Health partner to expand access to clinical trials
Premium
The Fly
Bayer, Henry Ford Health partner to expand access to clinical trials
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >